---
figid: PMC4167483__nihms615540f2
figtitle: Sonic Hedgehog Signaling in Basal Cell Nevus Syndrome
organisms:
- Homo sapiens
- Mus musculus
- Paraechinus aethiopicus
pmcid: PMC4167483
filename: nihms615540f2.jpg
figlink: /pmc/articles/PMC4167483/figure/F2/
number: F2
caption: The Hh signaling pathway demonstrates complex crosstalk with multiple signaling
  pathways that modulate cancer pathogenesis. The TNF-mTOR pathway activates Gli1
  in a SMO-independent manner. Activated mTOR enhances Gli1 transcriptional activity
  and oncogenic functions via S6K1-mediated Gli1 phosphorylation at Ser84 which helps
  to release Gli1 from SUFU. IGF/PI3K/Akt pathway regulates Gli1/2 activities involving
  modulation of PKA-dependent phosphorylation of Glis, and so are the EGFR/MEK/ERK
  or TGFβ signaling pathways. In addition, TGFβ can directly induce Gli2 expression
  independent of Hh signaling and requires Smad3. Wnt signaling also modulates Hh
  activity although the underlying cascade remains unclear. Coding region determinant-binding
  protein (CRD-BP), a direct target of Wnt/βCatenin signaling, can bind with Gli1
  mRNA promoting tumor growth. Hh signaling can also regulate Wnt signaling through
  modulation of βCatenin. Atypical protein kinase C ι/λ (aPKC-ι/λ) acts downstream
  of SMO to phosphorylate and activate Gli1, resulting in its maximal DNA binding
  and transcriptional activation. GliA, Gli activator; GliR, Gli repressor; TCF, T-cell
  factor; LEF, lymphoid enhancer binding factor.
papertitle: Sonic Hedgehog Signaling in Basal Cell Nevus Syndrome.
reftext: Mohammad Athar, et al. Cancer Res. ;74(18):4967-4975.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9416615
figid_alias: PMC4167483__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4167483__F2
ndex: 9ba44aad-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4167483__nihms615540f2.html
  '@type': Dataset
  description: The Hh signaling pathway demonstrates complex crosstalk with multiple
    signaling pathways that modulate cancer pathogenesis. The TNF-mTOR pathway activates
    Gli1 in a SMO-independent manner. Activated mTOR enhances Gli1 transcriptional
    activity and oncogenic functions via S6K1-mediated Gli1 phosphorylation at Ser84
    which helps to release Gli1 from SUFU. IGF/PI3K/Akt pathway regulates Gli1/2 activities
    involving modulation of PKA-dependent phosphorylation of Glis, and so are the
    EGFR/MEK/ERK or TGFβ signaling pathways. In addition, TGFβ can directly induce
    Gli2 expression independent of Hh signaling and requires Smad3. Wnt signaling
    also modulates Hh activity although the underlying cascade remains unclear. Coding
    region determinant-binding protein (CRD-BP), a direct target of Wnt/βCatenin signaling,
    can bind with Gli1 mRNA promoting tumor growth. Hh signaling can also regulate
    Wnt signaling through modulation of βCatenin. Atypical protein kinase C ι/λ (aPKC-ι/λ)
    acts downstream of SMO to phosphorylate and activate Gli1, resulting in its maximal
    DNA binding and transcriptional activation. GliA, Gli activator; GliR, Gli repressor;
    TCF, T-cell factor; LEF, lymphoid enhancer binding factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMO
  - SMOX
  - PTCH1
  - SUFU
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - GLI1
  - TNF
  - MTOR
  - RPS6KB1
  - IGF1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GSK3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LRP6
  - LRP5
  - AKT1
  - AKT2
  - AKT3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - GANAB
  - EGF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - IGF2BP1
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD3
  - GLI2
  - CCND1
  - HNF4A
  - Smo
  - Smox
  - Ptch1
  - Sufu
  - Gabrg2
  - Tnf
  - Mtor
  - Rps6kb1
  - Gsk3b
  - Pik3r1
  - Lrp6
  - Lrp5
  - Akt1
  - Egf
  - Mdk
  - Ephb2
  - Mapk1
  - Igf2bp1
  - Tgfb1
  - Ltbp1
  - Smad3
  - Gli1
  - Gli2
  - Ccnd1
  - Cancer
---
